Discover
ANIX
Anixa Biosciences, Inc.
3.56
50 x 3.60
6 x 3.70
bid
ask
+
0.00
0.00%
50 @ 09:04 AM
3.75 +0.19 (5.34%)
| Ytd | 14.10% | |
| 1y | 3.79% |
day range
2.32
52 week range
5.46
| Open | Prev Close | 3.56 | Low | High | Mkt Cap | 121.12M | |||
| Vol | 0.00 | Avg Vol | 197.27K | EPS | -0.31 | P/E | -11.48 | Forward P/E | -7.17 |
| Beta | 0.59 | Short Ratio | 3.03 | Inst. Own | 17.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-10 | 50-d Avg | 2.85 | 200-d Avg | 3.29 | 1yr Est | 8.50 |
| Income Statement | |||
| Operating Expenses | 2.65M | ||
| Research and Development Expense | 1.26M | ||
| Selling, General and Administrative Expense | 1.39M | ||
| Operating Income | -2.65M | ||
| Net Income | -2.52M | ||
| Net Income Common Stock | -2.52M | ||
| Net Income Common Stock (USD) | -2.52M | ||
| Consolidated Income | -2.54M | ||
| Net Income to Non-Controlling Interests | -20.00K | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -2.52M | ||
| Earning Before Interest & Taxes (USD) | -2.52M | ||
| Weighted Average Shares | 33.59M | ||
| Weighted Average Shares Diluted | 33.59M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.48M | ||
| Cash and Equivalents (USD) | 1.48M | ||
| Investments | 12.21M | ||
| Investments Current | 12.21M | ||
| Trade and Non-Trade Receivables | 56.00K | ||
| Current Assets | 14.69M | ||
| Property, Plant & Equipment Net | 173.00K | ||
| Total Assets | 14.87M | ||
| Debt Current | 44.00K | ||
| Total Debt | 184.00K | ||
| Current Liabilities | 1.50M | ||
| Debt Non-Current | 140.00K | ||
| Total Liabilities | 1.64M | ||
| Accumulated Retained Earnings (Deficit) | -256.76M | ||
| Shareholders Equity | 14.48M | ||
| Shareholders Equity (USD) | 14.48M | ||
| Assets Non-Current | 173.00K | ||
| Total Debt (USD) | 184.00K | ||
| Liabilities Non-Current | 140.00K | ||
| Trade and Non-Trade Payables | 252.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 10.00K | ||
| Net Cash Flow from Financing | 1.25M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -70.00K | ||
| Issuance (Purchase) of Equity Shares | 1.25M | ||
| Net Cash Flow from Investing | 422.00K | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 422.00K | ||
| Net Cash Flow from Operations | -1.74M | ||
| Share Based Compensation | 665.00K | ||